Global Slide Stainer Market - 2020-2027
|出版日期||內容資訊||英文 213 Pages
|切片染色設備的全球市場（2020-2027） Global Slide Stainer Market - 2020-2027|
|出版日期: 2020年09月30日||內容資訊: 英文 213 Pages||
The Global Slide Stainer Market is expected to grow at a CAGR of 11% during the forecasting period (2020-2027).
A stainer is used to separate tissues or cells, toecast peri carry microscopic study and identification. A slide stainer automates the staining of prepared cytology or histology tissue specimens by diffusing dyes into the samples through direct or indirect staining, surface adsorption, or mordant staining. An automated slide stainer uses two processes, rotating transport and linear transport.
There is growing technological advancements in the slide stainers with a growing trend of laboratory processes automation. These are commonly used in labs for quality histology staining results. The development in the slide stainer market has seen some substantial improvements in their workflows, control and reporting capabilities, and overall productivity.
The global slide stainer market growth is driven by rising prevalence of chronic and infectious diseases, technological advancements, and growing demand for automation in diagnostics and clinical research.
Increasing prevalence of chronic diseases is expected to drive the market growth
The growing prevalence of chronic and life-threatening diseases is driving the pharmaceutical companies and research firms to focus on R&D activities to develop effective therapeutics. Strides made in lab instrumentation automation have led to the application of slide stainers in disease diagnosis and oncology research.
As per the International Diabetes Federation, diabetes patients spent US$ 760 billion in 2019, of which, most was spent by Type-1 diabetes patients on insulin drugs. Around 463 million adults (20-79 years) are living with diabetes currently, and by 2045 this is projected to rise to 700 million. The proportion of type 2 diabetes people is increasing in most countries. Also, as per the American Heart Association, in 2015, approximately 41.5% of the U.S. population was suffering from some form of cardiac disease, it is further estimated that this prevalence is likely to increase to 45% by 2035. According to the Centers for Disease Control and Prevention (CDC) of the U.S., about half of the population (47%) of the United States have at least one of these three risk factors.
According to the National Cancer Institute, the most common cancers are prostate cancer, breast cancer, lung and bronchus cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukaemia, pancreatic cancer, thyroid cancer and liver cancer. According to the National Cancer Institute, about 57% of new cancer cases in 2012 occurred in developing regions of the world which include Central America and parts of Africa and Asia; about 65% of cancer deaths also occurred in these regions.
Hence, the growing health burden of chronic and infectious diseases is a major factor boosting the demand for slide stainers, especially in developed countries. In developing countries, the prevalence of infectious diseases has increased the spending of the population on regular health checkups, which has encouraged healthcare providers such as hospitals to automate lab processes. This has increased the demand for high-performing slide stainers.
Rising adoption of automated slide stainers is expected to drive the market growth
The biotechnology and pharmaceutical companies mostly use slide stainers for the preparation of quality control slides. These companies biotechnology operate in a highly regulated market. Hence, the demand for standardized and rapid workflows has increased among these companies to meet the regulatory and quality standards. This has led to increasing adoption rate of automated slide stainer among pharmaceutical and biotechnology companies which reduces the manual interactions and errors and helps in reducing standardization and validation pressure on in-house laboratories.
The manufacturers are developing the automated slide stainers to meet specific requirements in various laboratory applications. Slide strainers with automated cleaning cycle and high-throughput capabilities can be processed in about 4-5 minutes. Both batch type staining and stain spraying can be performed in automated slide strainers. Vendors are manufacturing compact slide strainers with built-in design features. For instance, the Histo-Tek® SL Slide Stainer introduced an automated slide stainer offering a new level of convenience and standardization for your low-volume laboratory needs, all at a low total cost of ownership.
COVID-19 Impact Analysis
The global slide stainer market has received immense impetus from the COVID-19 pandemic, as stakeholders are increasingly searching for newer approaches towards diagnosing and curing patients affected by the COVID-19. Increasing research and development is being undertaken by several pharmaceutical and biotechnology companies. Thus, rising demand for clinical research is expected to generate several opportunities for the slide stainer manufacturers, hence, expected to boost the market growth over the forecast period.
By product, the reagents segment accounted for the largest share of the global slide stainers market in 2019
On the basis of product, the global slide stainer market is segmented into reagents, equipment, consumables & accessories. Among these, the reagents segment accounted for the largest share of the global slide stainers market in 2019, due to the growing prevalence of chronic and several life-threatening diseases and growing demand for automation in diagnostics and clinical research. In addition, the demand for automated instruments in hospitals and diagnostic laboratories is rising due to the rising burden of diseases and lack of skilled professionals.
Hematoxylin & eosin (H&E) segment is expected to hold the largest market share over the forecast period (2020-2027)
By technology, the slide stainer market is segmented into hematoxylin & eosin, immunohistochemistry, in situ hybridization, cytology, microbiology, haematology, and special stains. Among these, the hematoxylin & eosin (H&E) segment accounted for the largest share of the slide stainers market in 2019, as the hematoxylin & eosin staining is the initial staining technique for several diseases and is associated with better quality, ease of use, and higher throughput compared to other staining technologies. A range of user-specified staining protocols has made way to end-users in the slide stainer market. An array of slide stainer launched in the market in recent years are characterized by an effective reagent management system, high staining capacity to meet different staining protocols, and better safety controls.
Hospitals are expected to dominate the global Slide Stainer market during the forecast period.
By end-user, the market is segmented into hospitals, diagnostic centers, academic and research institutes, pharmaceutical and biotechnology companies, and others. Among these, the hospitals segment accounted for the largest market share in 2019, due to rising incidences of chronic diseases and huge patient inflow in hospitals and diagnostic centers. There is a rise in demand for slider strainers in hospitals and diagnostic laboratories to ease their workflow, enhance the performance by slide straining procedures in disease diagnostic applications.
North America region holds the largest market share global Slide Stainer market
North America region is dominating the global slide stainer market accounted for the largest market share in 2019, due to highly advanced healthcare system, ease of accessibility to technologically advanced instruments, increasing prevalence of cancer, and large presence of major key players in this region. There is a growing demand for slide strainers in disease diagnosis and cancer research in North America. The rising demand for efficient downtime management has prompted vendors to concentrate on establishing efficient supply chains in the regional market. The region is witnessing the growing adoption of automated devices and instruments such as automated and semiautomated slide stainers among the hospitals and diagnostic laboratories to reduce their workload. This is expected to drive the demand for automated instruments in the region over the forecast period. The United States and Canada are the major contributors to the growth of slide stainer in North America.
The slide stainer market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Agilent Technologies Inc., Danaher Corp., Sakura, BioGenex, Thermo Fisher Scientific, Biocare Medical, Merck Group, General Data Company, Hardy Diagnostics, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the slide stainer market globally. For instance, in March 2020, ELITechGroup Inc. launched the Aerospray Cytology Slide Stainer Cytocentrifuge which automates the preparation and staining of liquid-based cytology specimens to facilitate the examination of an array of cell differentiations utilizing Papanicolaou staining techniques. The device performs two functions of sample preparation through cytocentrifugation and sample staining.
Overview: Sakura Finetek, founded in 1986 with the U.S. office based in Torrance, California. It is the global leader in continuous innovation for pathology by providing integrated solutions for anatomic pathology and patients through best-in-class innovation, quality and customer care. Sakura Finetek is leading industry in the development and commercialization of automated histology instrumentation and consumables for anatomic pathology. The company specializes in pathology, histology, smart automation, tissue processors, tissue embedders, H&E stainers, coverslippers - film & glass, advanced staining - IHC & ISH, microtomes, cassette & slide printers, blades, grossing, storage systems - blocks & slides, cryostats, digital microscopes, histopathology, cancer diagnostics, tissue-Tek, accu-edge, and histology consumables
Histo-Tek® SL Slide Stainer: The Histo-Tek® SL Slide Stainer is an automated slide stainer offering a new level of convenience and standardization for your low-volume laboratory needs, all at a low total cost of ownership.
Histo-Tek® Mini Stainer: The Histo-Tek® Mini Stainer standardizes the staining process for optimal quality and consistency. This small, robust linear stainer is created to meet your laboratories demands.
Tissue-Tek Prisma® Plus Automated Slide Stainer: The Tissue-Tek Prisma® Plus Automated Slide Stainer remains the highest throughput stainer with up to 530 slides per hour while still producing consistent high quality slides.
Tissue-Tek Prisma® H&E Stain Kit :The Tissue-Tek Prisma® H&E Stain Kit #1 is the first and only H&E kit designed specifically for the Prisma line of stainers.
Key Development: In February 2018, Sakura Finetek USA, Inc. launched the Tissue-Tek Prisma Plus Automated Slide Stainer, making the already fastest histology slide stainer in the industry faster to 530 slides per hour.
Visualize the composition of the slide stainer market segmentation by product, technology, and end-user highlighting the key commercial assets and players.
Identify commercial opportunities in slide stainer market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of slide stainer market - level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the key product of all major market players
The global Slide Stainer market report would provide an access to an approx. 61 market data table, 58 figures and 230 pages.
Target Audience 2022
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
LIST NOT EXHAUSTIVE